TREATMENT WITH REMDESIVIR IN CATS WITH INFECTIVE PERITONITIS – CASE STUDY

Abstract

Feline infectious peritonitis (FIP) is common disease with wide spectrum of unspecific clinical signs, caused by feline coronavirus and is often with fatal outcome. Diagnosis can often be difficult and the test results should always be interpreted in conjunction with clinical signs, clinical examination findings and laboratory results. Lack of registered and available treatment for this disease is challenging for both owners and veterinary practitioners. The most recent promising treatment for cats with FIP is the use of the nucleoside analogue GS-441524, which is the active form of the prodrug Remdesivir. The goal of this study was to present successful treatment of 3 cats with different type of FIP. Clinical examination data, laboratory and rapid test results before and during treatment were evaluated. With this case study we present our positive experience with Remdesivir that can be used in all cats with FIP, regardless of the form of the disease.